Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,774,256
-$2,599,029 QoQ
Shares Held
572,535
-26.5% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#51
of 477 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2023CallValue
$1,945,317
CallShares
23,300
PutValue
$484,242
PutShares
5,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. CYTK ranks #16 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in CYTK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,774,256 | 572,535 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $51,373,285 | 779,446 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,138,580 | 537,277 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $496,728 | 9,038 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,024,998 | 121,822 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,711,071 | 117,220 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,988,451 | 63,530 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $79,427 | 1,466 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,105,263 | 30,028 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $29,266,166 | 350,535 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $1,945,317 | 23,300 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $484,242 | 5,800 | Put | Sole | 2024-02-13 | |
| 2023-09-30 | $285,997 | 9,708 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,117,036 | 95,556 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,606,904 | 102,498 | Shares | Sole | 2023-05-15 | |
| 2021-09-30 | $442,246 | 12,374 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $297,644 | 13,748 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $561,885 | 23,839 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||